The proposed study will use a randomized clinical trial design with non-equivalent control group and longitudinal design to evaluate the feasibility, acceptability, and preliminary effects of the Diabetes LIVE JustICE application. The design will incorporate repeated measures at 0, 6, and 12 weeks. Outcome variables will include recruitment assessments, participation, engagement, user experience, and measures proximally related to behavior change - e.g., diabetes knowledge, diabetes-related distress, diabetes self-care, and social support and clinical outcomes -e.g., glycemic control. Focus group interviewing will be conducted to evaluate acceptability among intervention group participants.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Demographics
Timeframe: baseline
Potential Confounding Effects
Timeframe: week 1
Potential Confounding Effects
Timeframe: week 2
Potential Confounding Effects
Timeframe: week 3
Potential Confounding Effects
Timeframe: week 4
Potential Confounding Effects
Timeframe: week 5
Potential Confounding Effects
Timeframe: week 6
Metabolic Indicator
Timeframe: baseline
Metabolic Indicator
Timeframe: week 12
Diabetes Knowledge
Timeframe: baseline
Diabetes Knowledge
Timeframe: week 6
Diabetes Knowledge
Timeframe: week 12
Diabetes-Related Emotional Distress
Timeframe: baseline
Diabetes-Related Emotional Distress
Timeframe: week 6
Diabetes-Related Emotional Distress
Timeframe: week 12
Self-management behaviors
Timeframe: baseline
Self-management behaviors
Timeframe: week 6
Self-management behaviors
Timeframe: week 12
Perceived Support for Diabetes Management
Timeframe: baseline
Perceived Support for Diabetes Management
Timeframe: week 6
Perceived Support for Diabetes Management
Timeframe: week 12
Perceived Competence Scale
Timeframe: baseline
Perceived Competence Scale
Timeframe: week 6
Perceived Competence Scale
Timeframe: week 12